# Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer Patients

> **NCT02583828** · NA · COMPLETED · sponsor: **Capital Medical University** · enrollment: 200 (actual)

## Conditions studied

- Breast Neoplasms
- Neoplasm Metastasis

## Interventions

- **DRUG:** Cyclophosphamide 50mg
- **DRUG:** Letrozole 2.5 mg

## Key facts

- **NCT ID:** NCT02583828
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2020-12
- **Final completion:** 2021-12
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2024-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02583828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02583828, "Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02583828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*